Neuregulin 1 in neural development, synaptic plasticity and schizophrenia
Open accessThe DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Abstract
Schizophrenia is a highly debilitating mental disorder that affects approximately 1% of the general population, yet it continues to be poorly understood. Recent studies have identified variations in several genes that are associated with this disorder in diverse populations, including those that encode neuregulin 1 (NRG1) and its receptor ErbB4. The past few years have witnessed exciting progress in our knowledge of NRG1 and ErbB4 functions and the biological basis of the increased risk for schizophrenia that is potentially conferred by polymorphisms in the two genes. An improved understanding of the mechanisms by which altered function of NRG1 and ErbB4 contributes to schizophrenia might eventually lead to the development of more effective therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Neuregulins are trophic factors that exist in both membrane-bound and soluble form. ErbB receptors are postsynaptic receptor tyrosine kinases and are activated on neuregulin binding47.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [47]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NRG1-ErbB4 signaling is well known to be strongly restricted to PV cells and to play an important role in neurodevelopment, neuroplasticity, and schizophrenia (Corfas et al., 2004;Mei and Xiong, 2008).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Mei and Xiong, 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Polymorphisms in NRG1 are associated with schizophrenia47.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [47]
In the citing paper
“NRG1 and ERBB4 mutant mice show several schizophrenia-relevant behavioral phenotypes, of which locomotor hyperactivity has been a consistent phenotype and can often be rescued through an acute dosage of the antipsychotic clozapine47.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [47]
In the citing paper
“NRG1–which encodes neuregulin 1, a cell-adhesion molecule that is implicated in synaptic plasticity and other functions22–exhibited a pattern ofexpression levels (across interneuron classes) that was highly correlated among humans, macaques and marmosets but quite distinct in mice and ferrets”
From Innovations present in the primate interneuron repertoire (2020) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 1×
“The activity of glutamic acid decarboxylase (GAD) and the staining of parvalbumin , a Ca 2+ -binding protein that is expressed in a subset of GABAergic interneurons, are reduced in the PFC of patients with schizophreni”
BackgroundCarlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Luskin, M. B. (1993) · Neuron · doi:10.1016/0896-6273(93)90281-u · Cited by 1,803
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683 · cited 1×
“Nrg1 +/− mice show a decrease in the number of functional NMDA receptors in their forebrai”
BackgroundPDZ domain proteins of synapses
Kim, E., & Sheng, M. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1517 · Cited by 1,577
Cited by
Items 401–500 of 1,001
Kizner, V., Naujock, M., Fischer, S. E., Jäger, S., Reich, S., Schlotthauer, I., Zuckschwerdt, K., Geiger, T., Hildebrandt, T., Lawless, N., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01727-1 · Cited by 32
Neuregulin induces CTGF expression in hypertrophic scarring fibroblasts
Kim, J.-S., Choi, I.-G., Lee, B., Park, J., Kim, J., Jeong, J. H., Jeong, J. H., & Seo, C. H. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1258-2 · Cited by 32
“cancer [20] and neurological disorders, such as schizophrenia [21].”
BackgroundBehavioral Phenotypes for Negative Symptoms in Animal Models of Schizophrenia
Miyamoto, Y., & Nitta, A. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r02cr · Cited by 35
TRP Channels and Psychiatric Disorders
Chahl, L. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_51 · Cited by 36
Animal Models of Schizophrenia
Yanagi, M., Southcott, S. A., Lister, J. M., & Tamminga, C. A. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00012-3 · Cited by 32
Ma, Z., Li, Q., An, H., Pankonin, M. S., Wang, J., & Loeb, J. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032714 · Cited by 31
Wang, Y.-Y., Zhao, B. T., Wu, M., Zheng, X., Lin, L., & Yin, D. (2021) · Nature Communications · doi:10.1038/s41467-020-20552-y · Cited by 37
Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1
Rösler, T. W., Depboylu, C., Arias-Carrión, Ó., Woźny, W., Carlsson, T., Höllerhage, M., Oertel, W. H., Schrattenholz, A. S., & Höglinger, G. U. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.033 · Cited by 31
Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans
Zheng, Y., Watakabe, A., Takada, M., Kakita, A., Namba, H., Takahashi, H., Yamamori, T., & Nawa, H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.021 · Cited by 33
“Neuregulin-1, neuroglycan C and heparin-binding EGF are expressed in the immature and mature central nervous system, where they contribute to brain development and functions (Tokita et al., 2007; Mei and Xiong, 2008).”
Choi, J., Young, J. A. T., & Callaway, E. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006233107 · Cited by 32
“At the same time, recent evidence has shown that schizophrenia is associated with mutations in both NRG and ErbB4 receptors (11).”
BackgroundMethodJajodia, A., Kaur, H., Kumari, K., Gupta, M., Baghel, R., Srivastava, A., Sood, M., Chadda, R. K., Jain, S., & Kukreti, R. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.031 · Cited by 32
Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders
Hayes, L. N., Shevelkin, A. V., Zeledón, M., Steel, G., Chen, P., Obie, C., Pulver, A. E., Avramopoulos, D., Valle, D. L., Sawa, A., et al. (2016) · Complex Psychiatry · doi:10.1159/000445836 · Cited by 37
Mostaid, M. S., Lee, T. T., Chana, G., Sundram, S., Weickert, C. S., Pantelis, C., Everall, I., & Bousman, C. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00225 · Cited by 33
“Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2011) 28(6):620–4.”
BackgroundJanssen, M. J., Leiva-Salcedo, E., & Buonanno, A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1420-12.2012 · Cited by 30
“The Neuregulin1 (NRG1)/ErbB4 signaling pathway is involved in several aspects of neurodevelopment (Mei and Xiong, 2008) and both genes are candidate contributors to susceptibility for schizophrenia (Harrison and Weinberger, 2005; Buonanno, 2010).”
BackgroundChildhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells
Hoffmann, A., Ziller, M. J., & Spengler, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123829 · Cited by 32
“Nrg1 signaling is a critical mediator of synaptic function and plasticity in glutamatergic signaling [124].”
BackgroundBerdiel‐Acer, M., Maia, A. R. R., Hristova, Z., Borgoni, S., Vetter, M., Burmester, S., Becki, C., Michels, B. E., Abnaof, K., Binenbaum, I., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01719-3 · Cited by 30
“We suggest that in our system, correlation of HAS2 and NRG1 is consequence of a regulatory mechanism in which NRG1 expressed by CAFs regulates HAS2 expression and modulates migratory potential of the fibroblasts by NRG1 non-canonical signaling (Mei & Nave, 2014, Mei & Xiong, 2008).”
BackgroundDong, B., Yang, Y., Han, D., & Wang, Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1174738 · Cited by 36
“Rather, there remain several high-risk genes that contribute to the hypofunction of NMDAR to increase the susceptibility to SZ, including neuregulin 1 (NRG1; Roy et al., 2007; Mei and Xiong, 2008; Kato et al., 2011), disrupted in schizophrenia-1 (DISC-1; Lipina et al.”
BackgroundIaci, J. F., Ganguly, A., Finklestein, S. P., Parry, T. J., Ren, J., Saha, S. G., Sietsma, D. K., Srinivas, M., Vecchione, A. M., & Caggiano, A. O. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.017 · Cited by 31
“The role of neuregulins in complex brain function has been primarily studied in neuregulin knock-outs and schizophrenia epidemiological studies (Mei and Xiong, 2008).”
BackgroundBACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia
Zhang, Z., Huang, J., Shen, Y., & Li, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00302 · Cited by 23
“…receptors involved in Nrg1/ErbB signaling pathways that ultimately increase ERK and AKT phosphorylation, which are necessary for cell survival, synaptic development, glutamatergic transmission (Krivosheya et al., 2008; Mei and Xiong, 2008), and remyelination (Hu et al., 2006; Luo et al., 2011).”
BackgroundNierode, G. J., Gopal, S., Kwon, P. S., Clark, D. S., Schaffer, D. V., & Dordick, J. S. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26839 · Cited by 34
Ying, J., Chew, Q. H., McIntyre, R. S., & Sim, K. (2023) · Genes · doi:10.3390/genes14030689 · Cited by 32
“Neuregulin-1 (NRG1) is involved in various neurodevelopmental processes, including cell migration, synaptic formation, plasticity, and myelination [73].”
BackgroundNeuregulin-1 beta 1 is implicated in pathogenesis of multiple sclerosis
Kataria, H., Hart, C. G., Alizadeh, A., Cossoy, M. B., Kaushik, D. K., Bernstein, C. N., Marrie, R. A., Yong, V. W., & Karimi‐Abdolrezaee, S. (2020) · Brain · doi:10.1093/brain/awaa385 · Cited by 30
Zhai, Q., Ren, Y., Ni, Q.-S., Song, Z., Ge, K., & Guo, Y. (2022) · Biomolecules · doi:10.3390/biom12030428 · Cited by 31
“Owing to the selective splicing at different parts of transcription products, NRG1 can be divided into α or β type, which has different affinity for different receptors [15].”
BackgroundCooper, M. A., & Koleske, A. J. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23615 · Cited by 29
“…mRNA and protein are elevated in affected areas of the schizophrenic brain, including the hippocampus and dorsal prefrontal cortex (Silberberg et al., 2006; Chong et al., 2008) where it functions in synapse maturation and plasticity (Li et al., 2007a; Krivosheya et al., 2008; Mei and Xiong, 2008).”
BackgroundErbB2 Receptor Over-Expression Improves Post-Traumatic Peripheral Nerve Regeneration in Adult Mice
Ronchi, G., Gambarotta, G., Scipio, F. D., Salamone, P., Sprio, A. E., Cavallo, F., Perroteau, I., Berta, G. N., & Geuna, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056282 · Cited by 29
“In mammals, there are several isoforms of NRG1, which can be soluble (type I/II) or transmembrane (type III), with different spatiotemporal patterns of expression [23,24,25,26].”
BackgroundMizuno, M., Sotoyama, H., Namba, H., Shibuya, M., Eda, T., Wang, R., Okubo, T., Nagata, K., Iwakura, Y., & Nawa, H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.29 · Cited by 30
Nawa, H., Sotoyama, H., Iwakura, Y., Takei, N., & Namba, H. (2014) · BioMed Research International · doi:10.1155/2014/697935 · Cited by 29
“Molecular cloning verified the presence of many EGFrelated peptides such as heparin-binding EGF-like growth factor (HB-EGF), transforming growth factor alpha (TGFα), amphiregulin, and neuregulins (NRG) [2, 3].”
BackgroundMoczulska, K. E., Pichler, P., Schutzbier, M., Schleiffer, A., Rumpel, S., & Mechtler, K. (2014) · Journal of Proteome Research · doi:10.1021/pr500456t · Cited by 30
Zhao, Y., He, A., Zhu, F., Ding, M., Hao, J., Fan, Q., Li, P., Liu, L., Du, Y., Liang, X., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.003 · Cited by 32
Genetic risk for white matter abnormalities in bipolar disorder
McIntosh, A. M., Hall, J., Lymer, G. K. S., Sussmann, J. E., & Lawrie, S. M. (2009) · International Review of Psychiatry · doi:10.1080/09540260902962180 · Cited by 29
Barrenschee, M., Lange, C., Cossais, F., Egberts, J.-H., Becker, T., Wedel, T., & Böttner, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00360 · Cited by 28
“This observation is in line with its abundant expression in the CNS and points to its dominant role in neurotransmission, neuroplasticity and glial-neuron interaction, as described before (Marchionni et al., 1999; Mei and Xiong, 2008; Ting et al., 2011).”
BackgroundMethodInfluentialWang, G., Zhang, D., Qin, L., Liu, Q., Tang, W., Liu, M., Xu, F., Tang, F., Cheng, L., Mo, H., et al. (2024) · Theranostics · doi:10.7150/thno.92700 · Cited by 29
Control of spinal motor neuron terminal differentiation through sustained Hoxc8 gene activity
Catela, C., Chen, Y., Weng, Y., Wen, K., & Kratsios, P. (2022) · University of Chicago · doi:10.6082/60c5f-ar171 · Cited by 28
Neuregulin4 Acts on Hypothalamic ErBb4 to Excite Oxytocin Neurons and Preserve Metabolic Homeostasis
Zhang, Y., Zhu, Y., Wang, J., Li, J., Guo, M., Chen, L., Zhang, L., Li, Y., Wan, B., Zhang, R., et al. (2023) · Advanced Science · doi:10.1002/advs.202204824 · Cited by 38
Huang, C.-H., Pei, J.-C., Luo, D.-Z., Chen, C., Chen, Y., & Lai, W. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00455 · Cited by 28
“NRG1, a trophic factor of neuregulin family, is a ligand and a receptor for epidermal growth factorlife receptor (ErbB) 1–4 and NRG1 has a transmembrane (TM) domain that is a critical motif for forward and reverse signaling cascade (Bao et al., 2003; Falls, 2003; Mei and Xiong, 2008).”
BackgroundNeuregulin-1 genotype is associated with structural differences in the normal human brain
Barnes, A., Isohanni, M. K., Barnett, J. H., Pietiläinen, O. P. H., Veijola, J. M., Miettunen, J., Paunio, T., Tanskanen, P., Ridler, K., Suckling, J., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.007 · Cited by 33
“Given that NRG-1 plays a role in synapse development, synaptic plasticity and neuronal survival (Mei and Xiong, 2008), it is highly plausible that genetic variation in NRG-1 genotypewill influence grey matter volume, and, if so, this could be a mechanism through which the gene is linked to risk for schizophrenia.”
BackgroundInfluentialDepboylu, C., Rösler, T. W., de Andrade, A., Oertel, W. H., & Höglinger, G. U. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13026 · Cited by 28
Hippocampal volume and the AKT signaling system in first-episode schizophrenia
Szamosi, A., Kelemen, O., & Kéri, S. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.12.005 · Cited by 30
“NRG1, a candidate susceptibility factor for psychotic disorders, acts on Epidermal Growth Factor receptors (ErbBs) and plays an essential role in neurodevelopment and synaptic plasticity (Harrison and Law, 2006;Mei and Xiong, 2008; Schmitt et al., 2008; Buonanno, 2010).”
BackgroundDisrupted Activity in the Hippocampal–Accumbens Circuit of Type III Neuregulin 1 Mutant Mice
Nason, M. W., Adhikari, A., Bozinoski, M., Gordon, J. A., & Role, L. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.180 · Cited by 31
“Thus Type III Nrg1-ErbB interactions constitute a prime example of bidirectional signaling in the nervous system(Bao et al., 2003; Hancock et al., 2008; Mei and Xiong, 2008).”
Increased NRG1-ErbB4 signaling in human symptomatic epilepsy
Zhu, J., Li, K., Cao, S.-X., Chen, X., Shen, C.-J., Zhang, Y., Geng, H.-Y., Chen, B., Lian, H., Zhang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00207-7 · Cited by 30
Matsukawa, R., Hirooka, Y., Nishihara, M., Ito, K., & Sunagawa, K. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834937d6 · Cited by 30
Kawata, M., Morikawa, S., Shiosaka, S., & Tamura, H. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.20 · Cited by 28
Morfill, C., Pankratova, S., Machado, P., Fernando, N., Regoutz, A., Talamona, F., Pinna, A., Kłosowski, M. M., Wilkinson, R. J., Fleck, R. A., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c14220 · Cited by 29
Pandya, C. D., & Pillai, A. (2014) · Cell Communication and Signaling · doi:10.1186/preaccept-8374202491198307 · Cited by 30
Potential therapeutic approaches for Angelman syndrome
Bi, X., Sun, J., Ji, A. X., & Baudry, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1115837 · Cited by 29
“been shown to activate the PI3K-mTOR pathway,[95] but whether this is the case in AS mice requires further studies.”
BackgroundBidirectional signaling of ErbB and Eph receptors at synapses
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2008) · Neuron Glia Biology · doi:10.1017/s1740925x09990287 · Cited by 31
Nie, S., Li, X., Tang, C., Min, F.-Y., Shi, X., Wu, L., Zhou, S., Chen, Z., Wu, J., Song, T., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.023 · Cited by 27
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer
Tomasich, E., Steindl, A., Paiato, C., Hatziioannou, T., Kleinberger, M., Berchtold, L., Puhr, R., Hainfellner, J. A., Müllauer, L., Widhalm, G., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0020 · Cited by 29
Neuregulin 1 Controls Glutamate Uptake by Up-regulating Excitatory Amino Acid Carrier 1 (EAAC1)
Yu, H.-N., Park, W.-K., Nam, K., Song, D., Kim, H., Baik, T., & Woo, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.591867 · Cited by 26
Support for the involvement of the ERBB4 gene in schizophrenia: A genetic association analysis
Lu, C.-L., Wang, Y.-C., Chen, J., Lai, I., & Liou, Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.067 · Cited by 28
Necl-2/CADM1 interacts with ErbB4 and regulates its activity in GABAergic neurons
Yamada, A., Inoue, E., Deguchi‐Tawarada, M., Matsui, C., Togawa, A., Nakatani, T., Ono, Y., & Takai, Y. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.06.003 · Cited by 28
“Interestingly, Nrg1 and ErbB4 are susceptibility genes for schizophrenia (Jaaro-Peled et al., 2009; Mei and Xiong, 2008).”
Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia
Barakat, A., Dean, B., Scarr, E., & Evin, G. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.001 · Cited by 30
“It plays important roles in the development and function of the CNS, including synapse formation, synaptic plasticity, neuronal migration, and myelination, and regulation of neurotransmitter receptors (Falls, 2003; Mei and Xiong, 2008).”
BackgroundInfluentialPei, J.-C., Liu, C., & Lai, W. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00126 · Cited by 29
“…roles for NRG1 in CNS development and function have been identified, including synapse formation, neuronal migration, axon guidance, axon myelination, synaptic plasticity, and the regulation of neurotransmitter expression (Harrison and Law, 2006; Mei and Xiong, 2008; Iwakura and Nawa, 2013).”
BackgroundMuthusamy, N., Chen, Y., Yin, D., Mei, L., & Bergson, C. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12989 · Cited by 27
Self-citationDevelopmental control of cortico-cerebral astrogenesis
Mallamaci, A. (2013) · The International Journal of Developmental Biology · doi:10.1387/ijdb.130148am · Cited by 32
Walsh, J., Tighe, O., Lai, D., Harvey, R. P., Karayiorgou, M., Gogos, J. A., Waddington, J. L., & O’Tuathaigh, C. M. P. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.027 · Cited by 29
Abbasy, S., Shahraki, F., Haghighatfard, A., Qazvini, M. G., Rafiei, S. T., Noshadirad, E., Farhadi, M., asl, H. R., Shiryazdi, A. A., Ghamari, R., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.022 · Cited by 35
“Type I is related to acetylcholine receptor inducing activity, type II is a Glial growth factor and type III is a sensory and motor neuron-derived factor [10], so expression changes in each type could affect specific function in brain independently or with other types.”
BackgroundIn Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
Koszła, O., Targowska‐Duda, K. M., Kędzierska, E., & Kaczor, A. A. (2020) · Biomolecules · doi:10.3390/biom10010160 · Cited by 28
Molecular and cellular characterization of Neuregulin‐1 type IV isoforms
Shamir, A., & Buonanno, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06677.x · Cited by 27
RNA detection in situ with FISH-STICs
Sinnamon, J. R., & Czaplinski, K. (2013) · RNA · doi:10.1261/rna.041905.113 · Cited by 26
“262 RNA, Vol. 20, No. 2 type III isoform is neuron-specific in the central nervous system (Mei and Xiong 2008).”
BackgroundNeuregulin Signaling Is Dispensable for NMDA- and GABAA-Receptor Expression in the CerebellumIn Vivo
Gajendran, N., Kapfhammer, J. P., Lain, E., Canepari, M., Vogt, K. E., Wisden, W., & Brenner, H. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4303-08.2009 · Cited by 27
“Based on their ability to elevate neurotransmitter receptor expression levels in cultured brain slices, neuregulin-1 isoforms have also been implicated in synapse-specific receptor expression in the central and peripheral nervous systems (for review, see Mei and Xiong, 2008).”
BackgroundLiu, C., Zhao, Y., Zhang, W., Dao, J.-J., Li, Q., Huang, J., Li, Z., Ma, Y., Qiao, C.-M., Cui, C., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03406-6 · Cited by 29
“NRG1-ErbB4 signaling is critically involved in various physiological functions of the nervous system, encompassing neuronal differentiation and migration, synaptic plasticity, and the synthesis and secretion of neurotrans-mitters [52].”
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease
Steinman, L., Patarca, R., & Haseltine, W. A. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221322 · Cited by 26
“NRG-1 regulates the thickness of the myelin sheath (reviewed in Mei and Xiong, 2008).”
BackgroundGao, Y.-Z., Wu, X., Zhou, Z., Liu, P., Yang, J., & Ji, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03278-y · Cited by 26
“It has been shown that ErbB4 receptors, the only autonomous receptor of NRG1, are specifically expressed in GABAergic neurons and particularly high in PV interneurons [35].”
BackgroundChamberlin, L. A., Yang, S.-S., McEachern, E., Lucas, J. T. M., McLeod, O. W., Rolland, C. A., Mack, N. R., Ferguson, B. R., & Gao, W. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01576-6 · Cited by 28
Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats
Taylor, S. B., Markham, J. A., Taylor, A. R., Kanaskie, B. Z., & Koenig, J. I. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.008 · Cited by 26
“Female pubertal onset and adult reproductive function Normal female sexual development has been shown to depend on proper NRG1-ErbB4 signaling [4].”
BackgroundInfluentialUmehara, T., Kawashima, I., Kawai, T., Hoshino, Y., Morohashi, K.-I., Shima, Y., Zeng, W., Richards, J. S., & Shimada, M. (2016) · Endocrinology · doi:10.1210/en.2016-1478 · Cited by 25
Schizophrenia-relevant behaviours of female mice overexpressing neuregulin 1 type III
Olaya, J. C., Heusner, C. L., Matsumoto, M., Weickert, C. S., & Karl, T. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.03.026 · Cited by 27
Digging deeper in the proteome of different regions from schizophrenia brains
Reis‐de‐Oliveira, G., Zuccoli, G. S., Fioramonte, M., Schimitt, A. C. B., Falkai, P., de Almeida, V., & Martins‐de‐Souza, D. (2020) · Journal of Proteomics · doi:10.1016/j.jprot.2020.103814 · Cited by 26
Kung, P.-L., Chou, T.-W., Lindman, M., Chang, N. P., Estevez, I., Buckley, B. D., Atkins, C., & Daniels, B. P. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02460-8 · Cited by 27
Effects of Amyloid-β Plaque Proximity on the Axon Initial Segment of Pyramidal Cells
León‐Espinosa, G., DeFelipe, J., & Muñoz, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112036 · Cited by 28
“Interestingly, Neuregulin 1 and its receptor ErbB4 are important risk genes for schizophrenia [88, 89].”
Tosato, S., Bellani, M., Bonetto, C., Ruggeri, M., Perlini, C., Lasalvia, A., Marinelli, V., Rambaldelli, G., Cristofalo, D., Bertani, M., et al. (2012) · Neuropsychobiology · doi:10.1159/000330584 · Cited by 24
Glutamate-dependent ectodomain shedding of neuregulin-1 type II precursors in rat forebrain neurons
Iwakura, Y., Wang, R., Inamura, N., Araki, K., Higashiyama, S., Takei, N., & Nawa, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174780 · Cited by 24
Chandrasekar, A., Heuvel, F. O., Wepler, M., Rehman, R., Palmer, A., Catanese, A., Linkus, B., Ludolph, A. C., Boeckers, T. M., Huber-Lang, M. S., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5270 · Cited by 26
“36 Although data on the expression of ERbB2 and ErbB3 are not as detailed, ErBB family members signal either as ERbB4 homodimers or as heterodimers of ErbB4, ErbB3, and Erbb2, 63 and therefore their expression is predicted to be comparable.”
Li, L., Shang, L., Kang, W., Du, L., & Ge, S. (2022) · Cell Biology International · doi:10.1002/cbin.11770 · Cited by 24
“…signaling by combining with ERBB, which includes ERBB2, ERBB3, and ERBB4, thereby activating the corresponding signal transduction pathways, which in turn affect cell growth, differentiation, adhesion, and migration (Jardé et al., 2020; Kirabo et al., 2017; Mei & Xiong, 2008; Yi et al., 2019).”
BackgroundA Glance at the Molecules That Regulate Oligodendrocyte Myelination
Wang, S., Wang, Y., & Zou, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44050149 · Cited by 24
Proteomic insights into mental health status: plasma markers in young adults
Afonin, A. М., Piironen, A., Maciel, I. D. S., Ivanova, M., Alatalo, A., Whipp, A. M., Pulkkinen, L., Rose, R. J., KAMP, I. V., Kaprio, J. A., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02751-z · Cited by 26
Golani, I., Tadmor, H., Buonanno, A., Kremer, I., & Shamir, A. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.09.011 · Cited by 24
Integrated analysis of receptor activation and downstream signaling with EXTassays
Botvinnik, A., Wichert, S. P., Fischer, T. M., & Rossner, M. J. (2009) · Nature Methods · doi:10.1038/nmeth.1407 · Cited by 26
“ErbB signaling has been implicated in developmental regulation, cancer progression and psychiatric disease”
BackgroundTakahashi, N., Nielsen, K. S., Aleksić, B., Petersen, S., Ikeda, M., Kushima, I., Vacaresse, N., Ujike, H., Iwata, N., Dubreuil, V., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.016 · Cited by 27
The response of neuregulin 1 mutant mice to acute restraint stress
Chesworth, R., Yulyaningsih, E., Cappas, E., Arnold, J. C., Sainsbury, A., & Karl, T. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.024 · Cited by 27
Effects of the antipsychotics haloperidol, clozapine, and aripiprazole on the dendritic spine
Takaki, M., Kodama, M., Mizuki, Y., Kawai, H., Yoshimura, B., Kishimoto, M., Sakamoto, S., Okahisa, Y., & Yamada, N. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.004 · Cited by 26
Nrg1 Intracellular Signaling Is Neuroprotective upon Stroke
Navarro-González, C., Huerga-Gómez, A., & Fazzari, P. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3930186 · Cited by 25
“The NRG1 gene generates six types of protein and more than 20 isoforms that are differentially expressed during development and regulated by neuronal activity [1, 30].”
BackgroundInfluentialSato, T., Sato, F., Kamezaki, A., Sakaguchi, K., Tanigome, R., Kawakami, K., & Sehara‐Fujisawa, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127360 · Cited by 27
“NRG1 is a member of epidermal growth factor (EGF) ligand family, and binds to ErbB3 and ErbB4 receptor tyrosine kinases [8,9].”
BackgroundInfluentialErbB3–ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas
Capparelli, C., Rosenbaum, S. R., Berman-Booty, L. D., Salhi, A., Gaborit, N., Zhan, T., Chervoneva, I., Roszik, J., Woodman, S. E., Davies, M. A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2959 · Cited by 24
“The NRG1 gene generates at least 31 isoforms through alternative promoter usage and splicing (38).”
NRG1 and BDNF genes in schizophrenia: An association study in an Italian case-control sample
Squassina, A., Piccardi, P., Zompo, M. D., Rossi, A., Vita, A., Pini, S., Mucci, A., & Galderisi, S. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.03.017 · Cited by 24
“However, several authors have shown positive association for other NRG1 SNPs and haplotypes, confirming the pivotal role of this gene in modulating susceptibility to schizophrenia (Mei and Xiong, 2008).”
Du, Y., Yang, H., Xu, Y., Cang, X., Luo, C., Mao, Y., Wang, Y., Qin, G., Luo, X., & Jiang, H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211941d · Cited by 23
Hasan, A., Roeh, A., Leucht, S., Langguth, B., Hansbauer, M., Oviedo-Salcedo, T., Kirchner, S. K., Papazova, I., Löhrs, L., Wagner, E. M., et al. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100537 · Cited by 23
Sotoyama, H., Namba, H., Tohmi, M., & Nawa, H. (2023) · Biomolecules · doi:10.3390/biom13020372 · Cited by 26
Neuregulin1 alpha activates migration of neuronal progenitors expressing ErbB4
Fornasari, B. E., Soury, M. E., Marchis, S. D., Perroteau, I., Geuna, S., & Gambarotta, G. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.10.008 · Cited by 23
Geng, H.-Y., Zhang, J., Yang, J., Li, Y., Wang, N., Ye, M., Chen, X.-J., Lian, H., & Li, X. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3948-16.2017 · Cited by 23
“Erbb4 is a susceptibility gene of schizophrenia (Mei and Xiong, 2008).”
BackgroundHao, J., Chen, Y., Yao, E., & Liu, X. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.002 · Cited by 27
Level of plasma neuregulin-1 SMDF is reduced in patients with idiopathic Parkinson’s disease
Hama, Y., Yabe, I., Wakabayashi, K., Kano, T., Hirotani, M., Iwakura, Y., Utsumi, J., & Sasaki, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.024 · Cited by 23
Strachan, R. T., Allen, J., Sheffler, D. J., & Roth, B. L. (2010) · Biochemistry · doi:10.1021/bi901921k · Cited by 25
“Interestingly, the ErbB4 neuregulin receptor, which is a member of the EGFR family, is expressed throughout the mature brain and is known to reside in some of the same cortical layers (47) as the 5HT2A receptor (48).”
BackgroundZhang, N., Zhong, P., Shin, S. M., Metallo, J., Danielson, E., Olsen, C. M., Liu, Q.-S., & Lee, S. H. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3658-14.2015 · Cited by 24
“Notably, mutations in ErbB4 and neuroligins are also found in SZ (Mei and Xiong, 2008; Sun et al., 2011).”
BackgroundInfluentialNeuregulin directed molecular mechanisms of visual cortical plasticity
Grieco, S. F., Holmes, T. C., & Xu, X. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24414 · Cited by 26
“…(Birchmeier, 2009; Britsch, 2007; Buonanno & Fischbach, 2001; Buonanno et al., 2008; Corfas, Roy, & Buxbaum, 2004; Esper, Pankonin, & Loeb, 2006; Falls, 2003; Fischbach, 2007; Gassmann & Lemke, 1997; Iwakura & Nawa, 2013; Mei & Nave, 2014; Mei & Xiong, 2008; Rico & Marin, 2011; Talmage, 2008).”
O’Tuathaigh, C. M. P., Fumagalli, F., Desbonnet, L., Perez-Branguli, F., Moloney, G., Loftus, S., O’Leary, C., Petit, E., Cox, R., Tighe, O., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw120 · Cited by 22
Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia
Peitl, V., Silić, A., Orlović, I., Vidrih, B., Crnković, D., & Karlović, D. (2020) · Neuropsychobiology · doi:10.1159/000504577 · Cited by 22
Synaptic plasticity in schizophrenia pathophysiology
Zhang, K., Liao, P., Wen, J., & Hu, Z. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.01.008 · Cited by 27
“Neuregulin 1 (NRG1) is a trophic factor that has an epidermal growth factor (EGF)-like domain signaling through ErbB receptor (Mei and Xiong, 2008).”
BackgroundRadonjić, N. V., Jakovčevski, I., Bumbasirevic, V. Z., & Petronijević, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2999-7 · Cited by 28
Metadata
- Authors
- Mei, L., & Xiong, W.-C.
- Affiliations
- Augusta University (US)
- Corresponding author
- Mei, Lin
- Venue
- Nature Reviews Neuroscience
- Published
- 2008-05-14
- Volume
- 9
- Issue
- 6
- Pages
- 437-452
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC2682371
- OpenAlex
- W2016717347
- Cited by
- 1,030
- References
- 212
- Citations by year
- 2026: 34 · 2025: 32 · 2024: 32 · 2023: 44 · 2022: 53 · 2021: 59 · 2020: 53 · 2019: 31 · 2018: 56 · 2017: 56 · 2016: 52 · 2015: 67 · 2014: 82 · 2013: 83 · 2012: 67
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Institute of Mental Health (R01MH083317, R21MH083563)
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- neuregulin-1, ErbB4, schizophrenia, neural development, synaptic plasticity, genetic polymorphism, schizophrenia risk genes
- MeSH terms
- Animals, Brain, Humans, Neuronal Plasticity, Polymorphism, Genetic, Schizophrenia, Synapses, Signal Transduction, Genetic Predisposition to Disease, Neuregulin-1, ErbB Receptors, Receptor, ErbB-4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.